Tirzepatide is a synthetic peptide agonist of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. FDA-approved as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic…